Peregrine Capital Management LLC Has $9.92 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Peregrine Capital Management LLC lowered its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 8.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,382 shares of the company's stock after selling 9,412 shares during the period. Peregrine Capital Management LLC owned approximately 0.12% of HealthEquity worth $9,920,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in HQY. Holocene Advisors LP bought a new stake in shares of HealthEquity in the 3rd quarter worth $1,246,000. GSA Capital Partners LLP bought a new stake in shares of HealthEquity in the 3rd quarter worth $638,000. Natixis Advisors LLC raised its stake in shares of HealthEquity by 29.8% in the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock worth $17,122,000 after buying an additional 48,009 shares in the last quarter. Vaughan Nelson Investment Management L.P. raised its stake in shares of HealthEquity by 36.7% in the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock worth $69,034,000 after buying an additional 226,563 shares in the last quarter. Finally, Loomis Sayles & Co. L P raised its stake in shares of HealthEquity by 2.2% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company's stock worth $92,216,000 after buying an additional 24,665 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the business's stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 39,000 shares of company stock worth $3,895,788 over the last 90 days. 2.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. The Goldman Sachs Group assumed coverage on HealthEquity in a research note on Friday, November 15th. They issued a "neutral" rating and a $108.00 price objective on the stock. Royal Bank of Canada lifted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a report on Tuesday, December 10th. Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 target price on the stock. Barrington Research lifted their target price on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Monday, December 2nd. Finally, Bank of America lifted their target price on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a report on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, HealthEquity presently has an average rating of "Moderate Buy" and a consensus target price of $110.71.

HealthEquity Stock Down 2.8 %

Shares of HQY stock traded down $3.12 on Friday, reaching $108.60. 587,767 shares of the company's stock traded hands, compared to its average volume of 731,005. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a market capitalization of $9.41 billion, a P/E ratio of 99.63, a price-to-earnings-growth ratio of 1.63 and a beta of 0.55. The business's 50 day moving average price is $103.66 and its two-hundred day moving average price is $92.05.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the company posted $0.40 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.